Centre for Cardiovascular Science, University of Edinburgh, Little France Crescent, Edinburgh, United Kingdom.
Circulation. 2012 Jan 3;125(1):76-86. doi: 10.1161/CIRCULATIONAHA.111.051052. Epub 2011 Nov 16.
The pathophysiology of aortic stenosis is incompletely understood, and the relative contributions of valvular calcification and inflammation to disease progression are unknown.
Patients with aortic sclerosis and mild, moderate, and severe stenosis were compared prospectively with age- and sex-matched control subjects. Aortic valve severity was determined by echocardiography. Calcification and inflammation in the aortic valve were assessed by 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG) uptake with the use of positron emission tomography. One hundred twenty-one subjects (20 controls; 20 aortic sclerosis; 25 mild, 33 moderate, and 23 severe aortic stenosis) were administered both 18F-NaF and 18F-FDG. Quantification of tracer uptake within the valve demonstrated excellent interobserver repeatability with no fixed or proportional biases and limits of agreement of ±0.21 (18F-NaF) and ±0.13 (18F-FDG) for maximum tissue-to-background ratios. Activity of both tracers was higher in patients with aortic stenosis than in control subjects (18F-NaF: 2.87±0.82 versus 1.55±0.17; 18F-FDG: 1.58±0.21 versus 1.30±0.13; both P<0.001). 18F-NaF uptake displayed a progressive rise with valve severity (r(2)=0.540, P<0.001), with a more modest increase observed for 18F-FDG (r(2)=0.218, P<0.001). Among patients with aortic stenosis, 91% had increased 18F-NaF uptake (>1.97), and 35% had increased 18F-FDG uptake (>1.63). A weak correlation between the activities of these tracers was observed (r(2)=0.174, P<0.001).
Positron emission tomography is a novel, feasible, and repeatable approach to the evaluation of valvular calcification and inflammation in patients with aortic stenosis. The frequency and magnitude of increased tracer activity correlate with disease severity and are strongest for 18F-NaF.
http://www.clinicaltrials.gov. Unique identifier: NCT01358513.
主动脉瓣狭窄的病理生理学尚未完全阐明,瓣叶钙化和炎症对疾病进展的相对贡献尚不清楚。
前瞻性比较了主动脉瓣硬化和轻度、中度、重度主动脉瓣狭窄患者与年龄和性别匹配的对照组。通过超声心动图确定主动脉瓣严重程度。采用正电子发射断层扫描(PET),用 18F-氟化钠(18F-NaF)和 18F-氟脱氧葡萄糖(18F-FDG)摄取评估主动脉瓣钙化和炎症。121 例患者(20 例对照;20 例主动脉瓣硬化;25 例轻度、33 例中度和 23 例重度主动脉瓣狭窄)同时接受了 18F-NaF 和 18F-FDG 检查。定量分析瓣膜内示踪剂摄取,观察者间重复性良好,无固定或比例偏差,最大组织-背景比的一致性界限为±0.21(18F-NaF)和±0.13(18F-FDG)。主动脉瓣狭窄患者的两种示踪剂活性均高于对照组(18F-NaF:2.87±0.82 比 1.55±0.17;18F-FDG:1.58±0.21 比 1.30±0.13;均 P<0.001)。18F-NaF 摄取随瓣膜严重程度呈渐进性升高(r(2)=0.540,P<0.001),18F-FDG 摄取略有升高(r(2)=0.218,P<0.001)。在主动脉瓣狭窄患者中,91%有 18F-NaF 摄取增加(>1.97),35%有 18F-FDG 摄取增加(>1.63)。两种示踪剂活性之间呈弱相关(r(2)=0.174,P<0.001)。
正电子发射断层扫描是一种评估主动脉瓣狭窄患者瓣叶钙化和炎症的新的、可行的和可重复的方法。示踪剂活性的频率和幅度与疾病严重程度相关,18F-NaF 最强。